分子病理辅助诊断Spitz样黑色素细胞肿瘤
针对组织病理学难以分类的黑色素细胞增生(含Spitz样形态),通过基因分析辅助区分良性痣与黑色素瘤。四例中两例基因结果提供决定性诊断信息,提示在常规临床中突变谱分析有诊断价值。作者建议对交界性或非典型病变纳入基因检测以支持准确分类。
要点
- 组织病理学仍是黑色素细胞增生分类的决定性手段。
- 对交界性或非典型Spitz样病变可考虑基因突变谱分析辅助分类。
- 四例中两例基因结果支持明确诊断。
核心结论
- 在组织病理学标准模棱两可的黑色素细胞增生中,基因分析可为分类提供有价值的信息。
- 推荐对交界性或非典型病变纳入基因突变谱分析以支持准确分类。
研究设计与样本
- 本文呈现四例组织病理学标准不明确的黑色素细胞增生病例,应要求进行基因分析以辅助分类。
主要发现
- 四例中有两例的基因结果提供了有价值的见解,使诊断得以明确。
- 遗传学研究已显示原发黑色素瘤亚型与Spitz痣的突变谱存在差异。
临床怎么用
- 组织病理学评估仍是黑色素细胞增生分类的决定性手段。
- 对边界性或非典型病变,可纳入基因突变谱分析以辅助准确分类。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Accurate classification of melanocytic proliferations has important implications for prognostic prediction, treatment and follow-up. Although most melanocytic proliferations can be accurately classified using clinical and pathological criteria, classification (specifically distinction between nevus and melanoma) can be challenging in a subset of cases, including those with spitzoid morphology. Genetic studies have shown that mutation profiles differ between primary melanoma subtypes and Spitz nevi. These differences may aid in distinguishing benign from malignant in some melanocytic tumours. Here, we present a selection of melanocytic proliferations with equivocal histopathological criteria, wherein genetic analysis was requested to help guide classification. In two of four cases, the genetic results offered valuable insights, allowing a definitive diagnosis, indicating the diagnostic value of mutation profiling in a real-world routine clinical setting. Although histopathological assessment remains decisive in melanocytic proliferation classification, we recommend including genetic profiling in cases of borderline or atypical lesion to support accurate classification.
引用
- Zaremba A, Lodde G, Murali R, et al. Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphology. Eur J Cancer. 2021. PMID: 33773277. doi:10.1016/j.ejca.2021.02.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。